Advertisement

European Journal of Clinical Pharmacology

, Volume 26, Issue 1, pp 19–22 | Cite as

Haemodynamic evaluation of Ibopamine in severe congestive heart failure

  • G. C. Reffo
  • M. Turrin
  • A. Gabellini
  • C. Forattini
  • Paolo Ghirardi
Originals

Summary

Ten patients suffering from refractory congestive heart failure were treated orally with Ibopamine 100 mg. The haemodynamic effects were evaluated with a Swan-Ganz catheter and thermodilution technique, 1 and 2 h after treatment. Ibopamine significantly increased the cardiac index and stroke work index, and decreased pulmonary pressure and the pulmonary and peripheral vascular resistances without affecting heart rate or blood pressure.

Key words

ibopamine congestive heart failure haemodynamic effects side effects 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Murphy GW, Schreiner BF, Bleakley PL, Yu PN (1964) Left ventricular performance following digitalization in patients with and without heart failure. Circulation 30: 558Google Scholar
  2. 2.
    Cohn K, Selzer A, Kersh ES, Karpman LS, Goldschlager N (1975) Variability of hemodynamic responses to acute digitalization in chronic cardiac failure due to cardiomyopathy and coronary artery disease. Am J Cardiol 35: 461Google Scholar
  3. 3.
    Visioli O, Cucchini F, Dei Cas L (1982) Farmaci inotropi positivi adrenergici. Atti XLIII Congresso Nazionale della Società Italiana di Cardiologia, Roma 16–19 Dicembre 1982, p 95Google Scholar
  4. 4.
    Rajfer SI, Goldberg LI (1982) Dopamine in the treatment of heart failure. Eur Heart J 3: (Suppl D) 103Google Scholar
  5. 5.
    Chatterjee K, Bendersky R, Parmley WW (1982) Dobutamine in heart failure. Eur Heart J 3: (Suppl D) 107Google Scholar
  6. 6.
    Klein NA, Siskind SJ, Frishman WH, Sonnenblick EH, Lejemtel TH (1981) Hemodynamic comparison of intravenous Amrinone and Dobutamine in patients with chronic congestive heart failure. Am J Cardiol 48: 170Google Scholar
  7. 7.
    Lejemtel TH, Keung E, Ribner HS, Davis R, Wexler J, Blanfox MD, Sonnenblick EH (1980) Sustained beneficial effects of oral Amrinone and cardiac and renal function in patients with severe congestive heart failure. Am J Cardiol 45: 123Google Scholar
  8. 8.
    Rubin SA, Lee S, O'Connor L, Hubenette A, Tober J, Swan HJC (1979) Thrombocytopenia and fever in a patient taking Amrinone. N Engl J Med 301: 1185Google Scholar
  9. 9.
    Merlo L, Brusoni B, Mussini E, Ghirardi P (1981) Attività della Ibopamina su alterazioni della emodinamica del distretto renale indotte sperimentalmente nel cane narcotizzato. Boll Soc Ital Cardiol 24: 1569Google Scholar
  10. 10.
    Merlo L, Brusoni B, Mussini E, Ghirardi P (1982) Activity of di-isobutyric ester of N-metil dopamine (Ibopamine) on regional haemodynamics of anaesthetized dogs. Symposium on Dopamine receptors agonists, Stockholm, April 20–23, 1982Google Scholar
  11. 11.
    Ghirardi P, Bauer R, Brusoni B (1980) Effets d'un dérivé de la dopamine actif par voie orale sur l'excrétion rénale. Nouv Presse Med 9: 453Google Scholar
  12. 12.
    Dei Cas L, Manca C, Vasini G, Mansour M, Bernardini B, Visioli O (1980) Non-invasive evaluation of left ventricular function through systolic times intervals following oral administration of SB 7505 in man. Arzneimittelforsch 30: 498Google Scholar
  13. 13.
    Dei Cas L, Vasini G, Manca C, Bernardini B, Visioli O (1982) Non invasive evaluation of the effects of oral Ibopamine (SB 7505) on cardiac and renal function in patients with congestive heart failure. J Cardiovasc Pharmacol 4: 370Google Scholar
  14. 14.
    Functional Classification of Heart Disease (1966) In: Friedberg CK (ed) Disease of the heart. WB Saunders, Philadelphia, p 241Google Scholar
  15. 15.
    Marzo A, Ghirardi P, Riva O, Maggi GC, Scalvini A, Marchetti G (1976) Plasma turnover and excretion of K-strophanthoside-3H in human volunteers after parenteral administration. Naunyn Schmied Arch Pharm 294: 115Google Scholar
  16. 16.
    Marzo A, Ghirardi P, Cavalca L, Alessio R, Maggi GC, Piscitello F, Triulzi MO (1981) Plasma turnover and excretion of Deslanoside C-3H in man after parenteral administration. Farmaco 36: 501Google Scholar
  17. 17.
    Goldberg LI, Kohli JD (1981) Specific dopamine receptors in vascular smooth muscle. In: Vanhoutte P, Lensen I (eds) Vasodilation. Raven Press, New York, p 131Google Scholar
  18. 18.
    Longhini C, Musacci GF, Ansani L, Toselli T, Artioli M, Bianco L, Ghirardi P (1983) Effect of Ibopamine on peripheral haemodynamics. Eur J Clin Pharmacol 24: 585–589Google Scholar

Copyright information

© Springer-Verlag 1984

Authors and Affiliations

  • G. C. Reffo
    • 1
  • M. Turrin
    • 1
  • A. Gabellini
    • 1
  • C. Forattini
    • 1
  • Paolo Ghirardi
    • 2
  1. 1.Divisione Medicina, Ospedale Generale ProvincialeMonseliceItaly
  2. 2.Simes S.p.A. La CardioterapicaMilanoItalia

Personalised recommendations